327 related articles for article (PubMed ID: 32041504)
1. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
[TBL] [Abstract][Full Text] [Related]
2. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
3. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
Choe JY; Kim SK
Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
[TBL] [Abstract][Full Text] [Related]
4. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis.
El-Shehaby A; Darweesh H; El-Khatib M; Momtaz M; Marzouk S; El-Shaarawy N; Emad Y
J Clin Immunol; 2011 Oct; 31(5):848-56. PubMed ID: 21691937
[TBL] [Abstract][Full Text] [Related]
5. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
Elsaid DS; Abdel Noor RA; Shalaby KA; Haroun RA
Saudi J Kidney Dis Transpl; 2021; 32(1):19-29. PubMed ID: 34145111
[TBL] [Abstract][Full Text] [Related]
6. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
Schwartz N; Rubinstein T; Burkly LC; Collins CE; Blanco I; Su L; Hojaili B; Mackay M; Aranow C; Stohl W; Rovin BH; Michaelson JS; Putterman C
Arthritis Res Ther; 2009; 11(5):R143. PubMed ID: 19785730
[TBL] [Abstract][Full Text] [Related]
7. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
Dong X; Zheng Z; Luo X; Ding J; Li Y; Li Z; Li S; Rong M; Fu Y; Wu Z; Zhu P
Medicine (Baltimore); 2018 Apr; 97(16):e0343. PubMed ID: 29668584
[TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
9. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
Moloi MW; Rusch JA; Omar F; Ekrikpo U; Dandara C; Bello AK; Jayne D; Okpechi IG
Int Urol Nephrol; 2021 Sep; 53(9):1865-1873. PubMed ID: 33459955
[TBL] [Abstract][Full Text] [Related]
10. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus.
Wang C; Chen LL; Pan HF; Leng RX; Qin WZ; Ye DQ
Clin Rheumatol; 2012 Feb; 31(2):335-9. PubMed ID: 21968693
[TBL] [Abstract][Full Text] [Related]
11. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
12. Relationship between neutrophil gelatinase-associated lipocalin levels and disease parameters including clinicopathological parameters and various cytokine levels in systemic lupus erythematosus.
Choi EW
J Vet Med Sci; 2023 Jun; 85(6):601-608. PubMed ID: 37088550
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis.
Dong XW; Zheng ZH; Ding J; Luo X; Li ZQ; Li Y; Rong MY; Fu YL; Shi JH; Yu LC; Wu ZB; Zhu P
Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067
[TBL] [Abstract][Full Text] [Related]
14. Urinary TWEAK and the activity of lupus nephritis.
Schwartz N; Su L; Burkly LC; Mackay M; Aranow C; Kollaros M; Michaelson JS; Rovin B; Putterman C
J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
[TBL] [Abstract][Full Text] [Related]
15. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
16. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
[TBL] [Abstract][Full Text] [Related]
17. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
[TBL] [Abstract][Full Text] [Related]
18. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
19. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis.
El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM
Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691
[TBL] [Abstract][Full Text] [Related]
20. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.
Xuejing Z; Jiazhen T; Jun L; Xiangqing X; Shuguang Y; Fuyou L
J Biomed Biotechnol; 2012; 2012():359647. PubMed ID: 22719208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
